We concluded that CYP26B1 is a novel candidate gene in the development of BQ-related oral cancer and speculated that CYP26B1 may be involved in the metabolism of arecoline-related compounds [48]. This evidence concerns the gene CYP26B1 and lip and oral cavity carcinoma.